Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid Remodeling.


Journal

Cell metabolism
ISSN: 1932-7420
Titre abrégé: Cell Metab
Pays: United States
ID NLM: 101233170

Informations de publication

Date de publication:
03 09 2019
Historique:
received: 04 12 2018
revised: 28 04 2019
accepted: 12 06 2019
pubmed: 16 7 2019
medline: 22 8 2020
entrez: 16 7 2019
Statut: ppublish

Résumé

Advances in DNA sequencing technologies have reshaped our understanding of the molecular basis of cancer, providing a precise genomic view of tumors. Complementary biochemical and biophysical perspectives of cancer point toward profound shifts in nutrient uptake and utilization that propel tumor growth and major changes in the structure of the plasma membrane of tumor cells. The molecular mechanisms that bridge these fundamental aspects of tumor biology remain poorly understood. Here, we show that the lysophosphatidylcholine acyltransferase LPCAT1 functionally links specific genetic alterations in cancer with aberrant metabolism and plasma membrane remodeling to drive tumor growth. Growth factor receptor-driven cancers are found to depend on LPCAT1 to shape plasma membrane composition through enhanced saturated phosphatidylcholine content that is, in turn, required for the transduction of oncogenic signals. These results point to a genotype-informed strategy that prioritizes lipid remodeling pathways as therapeutic targets for diverse cancers.

Identifiants

pubmed: 31303424
pii: S1550-4131(19)30317-1
doi: 10.1016/j.cmet.2019.06.014
pmc: PMC6742496
mid: NIHMS1532638
pii:
doi:

Substances chimiques

Phospholipids 0
epidermal growth factor receptor VIII 0
1-Acylglycerophosphocholine O-Acyltransferase EC 2.3.1.23
Lpcat1 protein, human EC 2.3.1.23
EGFR protein, human EC 2.7.10.1
ErbB Receptors EC 2.7.10.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

525-538.e8

Subventions

Organisme : NINDS NIH HHS
ID : P30 NS047101
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA211015
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS073831
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA231991
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Cell Metab. 2016 Mar 8;23(3):492-504
pubmed: 26833026
Cell Metab. 2016 Jan 12;23(1):27-47
pubmed: 26771115
Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102
pubmed: 28407145
Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15523-8
pubmed: 20713727
J Cell Sci. 2005 Mar 15;118(Pt 6):1099-102
pubmed: 15764592
EMBO J. 2006 Sep 20;25(18):4195-206
pubmed: 16932740
PLoS One. 2015 Mar 24;10(3):e0120143
pubmed: 25803864
Cancer Cell. 2016 Nov 14;30(5):683-693
pubmed: 27746144
Biophys J. 1997 Jun;72(6):2413-29
pubmed: 9168019
Cancer Res. 2007 Sep 1;67(17):8240-7
pubmed: 17804738
Science. 2010 Jan 1;327(5961):46-50
pubmed: 20044567
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
J Exp Clin Cancer Res. 2017 May 12;36(1):66
pubmed: 28494778
J Lipid Res. 2005 May;46(5):1061-7
pubmed: 15722565
Cancer Res. 2005 Feb 15;65(4):1479-88
pubmed: 15735036
Annu Rev Pathol. 2014;9:1-25
pubmed: 23937436
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
J Lipid Res. 2014 May;55(5):799-807
pubmed: 24646950
Science. 2014 Aug 8;345(6197):693-7
pubmed: 25104391
Nat Rev Cancer. 2016 Nov;16(11):732-749
pubmed: 27658529
Cancer Res. 2010 Oct 15;70(20):8117-26
pubmed: 20876798
Nat Rev Mol Cell Biol. 2008 Feb;9(2):112-24
pubmed: 18216768
J Mol Med (Berl). 2009 Jan;87(1):85-97
pubmed: 18974965
Ann Surg Oncol. 2016 Feb;23 Suppl 2:S206-13
pubmed: 25752890
Nat Commun. 2018 Jan 22;9(1):322
pubmed: 29358673
Cancer Res. 2006 Aug 15;66(16):7864-9
pubmed: 16912159
Tumour Biol. 2015 Jul;36(7):5473-83
pubmed: 25683484
Cancer Sci. 2013 Oct;104(10):1295-302
pubmed: 23815430
Trends Cell Biol. 2014 Jan;24(1):26-34
pubmed: 24295852
J Biol Chem. 2006 Jul 21;281(29):20140-7
pubmed: 16704971
Cell Metab. 2013 Aug 6;18(2):153-61
pubmed: 23791484
Cell Res. 2014 Aug;24(8):959-76
pubmed: 25001389
Elife. 2015 Apr 21;4:
pubmed: 25898003
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2830-5
pubmed: 18287005
Elife. 2016 Oct 04;5:
pubmed: 27700986
Cell. 2017 Jan 12;168(1-2):239-251.e16
pubmed: 28041850
Cell. 2010 Jan 8;140(1):49-61
pubmed: 20079333
Nat Protoc. 2012 May 03;7(6):1042-51
pubmed: 22555243
Nat Rev Mol Cell Biol. 2018 May;19(5):281-296
pubmed: 29410529
Cancer Res. 2011 May 1;71(9):3236-45
pubmed: 21415164
Science. 2014 Jan 3;343(6166):72-6
pubmed: 24310612
Nat Protoc. 2011 Dec 08;7(1):24-35
pubmed: 22157973
Cancer Res. 1962 Jun;22:525-48
pubmed: 13858936
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
J Biol Chem. 2005 Jul 22;280(29):26796-804
pubmed: 15917253
Cancer Res. 2003 Oct 1;63(19):6272-81
pubmed: 14559814
Cancer Cell. 2017 Dec 11;32(6):807-823.e12
pubmed: 29232555
Nature. 2017 Mar 2;543(7643):122-125
pubmed: 28178237
J Clin Invest. 2010 May;120(5):1736-48
pubmed: 20407208
Cell Stem Cell. 2018 Feb 1;22(2):206-220.e4
pubmed: 29395055
Nat Rev Cancer. 2018 Jan;18(1):33-50
pubmed: 29147025
Cell. 2013 Jan 31;152(3):557-69
pubmed: 23374350
Cancer Discov. 2011 Oct;1(5):442-56
pubmed: 22059152
Nat Rev Mol Cell Biol. 2017 Jun;18(6):361-374
pubmed: 28356571
Sci Signal. 2009 Dec 15;2(101):ra82
pubmed: 20009104
Cancer Res. 2001 Jul 15;61(14):5355-61
pubmed: 11454674
Cell. 2018 Apr 5;173(2):321-337.e10
pubmed: 29625050
J Biol Chem. 1958 Apr;231(2):883-8
pubmed: 13539023
Cell Metab. 2014 Aug 5;20(2):295-305
pubmed: 24981836
J Hepatol. 2013 Aug;59(2):292-9
pubmed: 23567080

Auteurs

Junfeng Bi (J)

Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA.

Taka-Aki Ichu (TA)

Department of Chemistry, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Ciro Zanca (C)

Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA.

Huijun Yang (H)

Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA.

Wei Zhang (W)

Department of Medicine, UCSD School of Medicine, La Jolla, CA 92093, USA.

Yuchao Gu (Y)

Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA; Department of Molecular and Medical Pharmacology David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA.

Sudhir Chowdhry (S)

Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA.

Alex Reed (A)

Department of Chemistry, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Shiro Ikegami (S)

Department of Neurological Surgery, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.

Kristen M Turner (KM)

Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA.

Wenjing Zhang (W)

Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA.

Genaro R Villa (GR)

Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA; Department of Molecular and Medical Pharmacology David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA.

Sihan Wu (S)

Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA.

Oswald Quehenberger (O)

Department of Medicine, UCSD School of Medicine, La Jolla, CA 92093, USA; Department of Pharmacology, UCSD School of Medicine, La Jolla, CA 92093, USA.

William H Yong (WH)

Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

Harley I Kornblum (HI)

Department of Molecular and Medical Pharmacology David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, David Geffen UCLA School of Medicine, Los Angeles, CA, USA.

Jeremy N Rich (JN)

Division of Regenerative Medicine, Department of Medicine, University of California, San Diego, San Diego, CA, USA.

Timothy F Cloughesy (TF)

Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

Webster K Cavenee (WK)

Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA; Department of Medicine, UCSD School of Medicine, La Jolla, CA 92093, USA; Moores Cancer Center, UCSD School of Medicine, La Jolla, CA 92093, USA.

Frank B Furnari (FB)

Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA; Department of Pathology, UCSD School of Medicine, La Jolla, CA 92093, USA; Moores Cancer Center, UCSD School of Medicine, La Jolla, CA 92093, USA.

Benjamin F Cravatt (BF)

Department of Chemistry, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Paul S Mischel (PS)

Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA; Department of Pathology, UCSD School of Medicine, La Jolla, CA 92093, USA; Moores Cancer Center, UCSD School of Medicine, La Jolla, CA 92093, USA. Electronic address: pmischel@ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH